Samsung Life (032830) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Samsung Life stock KRW 251,964, price KRW 244,500, upside +3.1%, quality 48 out of 100. Rating: fairly valued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
The stock costs about what our calculation considers fair.
2.2% dividend yield · Low payout
Broad data
Revenue last quarter +63% vs. a year ago.
Fair value 251,964 KRW · Fairly valued (+3.1%)
Quality 48/100
Thin margins · 8.9% net margin (TTM)
Weak Growth(revenue 5y −0.4 %/yr in KRW)
Trails peers(3/15)
Narrow moat34/100 · thin data
Risks from the AI analysis
🚩Accounting rule changes on Samsung Electronics stake🚩Overlap with Samsung Fire in third-sector insurance🚩Capital tied to Samsung Electronics share performance
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range 47,928 KRW – 497,000 KRW · fair‑value band 244,105 KRW – 345,884 KRW · the 244,500 KRW price screens below the 251,964 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Samsung Life in your weekly email
Every Wednesday you see whether Samsung Life is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Samsung Life Insurance Co., Ltd., together with its subsidiaries, engages in the life insurance business to corporate and individual customers in South Korea and internationally.
Show moreShow less
The company operates through Domestic Insurance; Credit Card Service, Installment Financing and Leasing; and Overseas segments. It also offers various loan products for companies, household, and stocks and bonds, as well as mortgage loans; and retirement pension, funds, and asset management services.
The company was formerly known as Dongbang Life Insurance and changed its name to Samsung Life Insurance Co., Ltd. in July 1989. Samsung Life Insurance Co., Ltd. was founded in 1957 and is headquartered in Seoul, South Korea.
Stock analysis
Samsung Life (032830) currently trades at 244,500 KRW, while our model-based Fair Value estimate is 251,964 KRW, so the stock looks roughly fairly valued today (gap 3.0%).
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of 251,964 KRW per share, and 2 of the 6 models we run sit above the 244,500 KRW price.
Bear case: the Dividend Discount group reads lowest at 48,626 KRW, and 4 of the 6 models stay below the price. Data coverage for this calculation is high.
Scenario range: 244,105 KRW (bear) to 345,884 KRW (bull), the price of 244,500 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Financial Services sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Samsung Life reported revenue of 28.5T KRW in FY2025 versus 28.5T KRW in FY2021, a compound 0.0%/yr. Reported net income was 2.3T KRW in FY2025, compounding +11.9%/yr from FY2021.
Key figures
Market cap 43.9T KRW (≈ $32.3B) Large · P/E ratio 15.2 · P/S ratio 1.40 · EPS (TTM) 15,605 KRW · Dividend yield 2.2% · Net margin 8.9% · Return on equity 3.3% · Return on assets (EBIT) 0.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 34 out of 100 (low confidence).
What moves the price
The share trades about 51% below its 52-week high and 75% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −39% fair-value upside, at 3%, 032830 screens cheaper than that median.
Fair Value models
Bear244,105 KRWFair Value 251,964 KRWBull345,884 KRW
Price 244,500 KRW · Upside +3.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (8,752 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+19.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.4%
Start year 2020 (pandemic). Over 10 years: +0.8% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+14.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+12.7%
Dividend (yield on the price)2.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.12.7% vs −45.1%, picking up
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 2.9%/yr over ~7Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −1.6% a year for the price.
AI conclusion: The Korean life insurer maintains strong solvency that supports overseas growth efforts but shows limited durable advantage due to low returns on equity and thin public evidence of a moat.
Main risk: Regulators ending the carve-out for Samsung Life's exceptional accounting treatment of participating policies linked to its Samsung Electronics stake could force reclassification of liabilities and reduce reported capital.
Bull case: Samsung Life could leverage its AI initiatives and senior-care expansion to shift toward prevention-focused and integrated life-care services that differentiate it from pure competitors and offset traditional product pressures.
Bear case: If regulatory accounting changes and competition intensify while the Samsung Electronics stake underperforms, Samsung Life might face sustained pressure on capital efficiency and profitability in its core domestic life insurance operations.
Samsung Life is preparing its first overseas issuance of hybrid capital securities worth up to 1.5 billion dollars to support international investments while preserving strong solvency. The company already reports a K-ICS ratio above 200 percent, so the raise is positioned for growth rather than immediate needs. Will the push abroad generate sustainable new profits or mainly add layers of currency and execution risk to a business still anchored at home?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Life · 77 stocks
Beats the industry median on 3/15 measures
Overall it trails its industry peers.
Valuation
Quality Score48 · Below median
Fair Value upside+3.1% · Above median
Profitability
Return on equity (12 months)3.3% · Bottom 25%
Return on assets0.7% · Below median
Net margin (12 months)8.9% · Below median
Operating margin (12 months)3.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)63.3% · Top 25%
Dividend yield (12 months)2.2% · Below median
Balance sheet
Debt / equity0.37× · Above median
Valuation Multiplesvs Insurance - Life median · lower = cheaper
P/E (12 months)15.2× · Pricier than median
P/B0.70× · Cheapest 25%
P/S (12 months)1.40× · Pricier than median
Price / free cash flow (fiscal year)8.6× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Samsung Life Fair Value". https://www.fairvalue-calculator.com/stock/032830
Frequently asked questions
Is Samsung Life (032830) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 251,964 KRW versus a price of 244,500 KRW, about +3% upside (fairly valued).
What is the fair value of 032830?
Our model-based fair value for Samsung Life is 251,964 KRW (as of Nov 6, 2026), built from audited fundamentals. The current price: 244,500 KRW.
What is the quality score of 032830?
Samsung Life has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Samsung Life (032830)?
Our model-based price target is the fair value of 251,964 KRW (as of Nov 6, 2026) from 6 valuation models. Cautious scenario 244,105 KRW, optimistic scenario 345,884 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Samsung Life stock forecast for 2026?
Our models put fair value at 251,964 KRW, about +3% upside versus a price of 244,500 KRW (fairly valued). Cautious scenario 244,105 KRW, optimistic scenario 345,884 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Samsung Life (032830)?
Samsung Life reported trailing-twelve-month revenue of about 31.4T KRW (latest available figure, as of Nov 6, 2026).
Does Samsung Life pay a dividend?
Samsung Life currently shows a dividend yield of 2.17% relative to its recent price (as of Nov 6, 2026).
What growth is priced into Samsung Life (032830)?
For today's price to be fair in a discounted-cash-flow model, Samsung Life would have to grow free cash flow by +0.5 % per year for five years (discount rate 9.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -0.4 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of 032830 use?
Our models discount Samsung Life at 9.8 %: a base by market capitalisation (large), damped by beta 1.07, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Samsung Life that is +0.5 % per year a year over ten years, using the same discount rate (9.8 %) and the same formula as our fair value.
How much growth has Samsung Life (032830) delivered so far?
Over the past 5 years revenue at Samsung Life grew -0.4 % a year. The price currently implies +0.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Samsung Life (032830) growing?
The median revenue growth in the sector is +9.4 % a year. That is the yardstick for the growth priced into Samsung Life (+0.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Samsung Life (032830)?
The free-cash-flow yield on the price is 11.59 %: that much free cash flow Samsung Life produces per unit of market value. When it exceeds the discount rate of our models (9.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Samsung Life (032830)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Samsung Life it is 251,964 KRW per share (as of Nov 6, 2026), against a price of 244,500 KRW. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Samsung Life stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 032830 trades below its calculated fair value: price 244,500 KRW, fair value 251,964 KRW, a gap of about +3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 032830?
No. The price is what the market pays today (244,500 KRW); the fair value is what the company's own numbers justify (251,964 KRW). For Samsung Life the two are 7,464 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Samsung Life worth?
The market values Samsung Life at about 43.9T KRW (market capitalisation, as of Nov 6, 2026). Per share that is 244,500 KRW; our models calculate a fair value of 251,964 KRW per share.
What do the bullish and bearish scenarios say about 032830?
Our models span a range for Samsung Life: cautious scenario 244,105 KRW, base 251,964 KRW, optimistic 345,884 KRW per share (as of Nov 6, 2026, price 244,500 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 032830?
Samsung Life trades at a price-to-earnings ratio of 15.2 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 251,964 KRW is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 8.4. Other multiples: PEG 1.5, P/B 0.7, P/S 1.4, EV/EBITDA 11.8.
What is the PEG ratio of 032830?
The PEG ratio of Samsung Life is 1.51 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Samsung Life (032830)?
Balance-sheet figures for Samsung Life (as of Nov 6, 2026): return on equity 3.3%, debt of 0.37 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is 032830 from its 52-week high?
Samsung Life trades at 244,500 KRW, about 51% below its 52-week high of 497,000 KRW and 75% above the low of 140,077 KRW (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of 251,964 KRW is for.
Which stocks are comparable to Samsung Life?
From the same area (Financial Services) we also value Ping An Insurance (Group) Company, China Life Insurance Company, AIA Group, Manulife Financial Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Samsung Life stock attractive at the current price?
The data as of Nov 6, 2026: price 244,500 KRW, calculated fair value 251,964 KRW (+3%), Quality Score 48/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 032830 calculated?
We run Samsung Life through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 251,964 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Samsung Life currently trades 3% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Samsung Life (032830)?
The closing price on Nov 5, 2026 was 244,500 KRW. Our model-based fair value is 251,964 KRW, about +3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Samsung Life right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Samsung Life
How large is the market capitalisation of Samsung Life (032830)?
The market capitalisation of Samsung Life is 43.9T KRW (≈ $32.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Samsung Life (032830)?
The price-to-sales ratio of Samsung Life is 1.40 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Samsung Life (032830)?
Earnings per share at Samsung Life are 15,605 KRW (price ÷ EPS = P/E 15.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Samsung Life (032830)?
The dividend yield of Samsung Life is 2.2% (payout 34.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Samsung Life (032830)?
The net margin of Samsung Life is 8.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Samsung Life (032830)?
The return on equity (ROE) of Samsung Life is 3.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Samsung Life (032830)?
On an EBIT basis the return on assets of Samsung Life is 0.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Samsung Life (032830)?
The operating margin of Samsung Life is 3.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Samsung Life (032830)?
Revenue at Samsung Life is growing +63.3% versus a year earlier (3y avg −0.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Samsung Life (032830)?
Earnings per share at Samsung Life are growing −9.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Samsung Life (032830) carry?
The net debt of Samsung Life is 17.1T KRW (fiscal year 2025, ≈ 3.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Samsung Life in the live analysis
One click puts Samsung Life on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 6, 2026